TETRA Technologies, Inc. (TTI) NYSE
8.73
+0.36(+4.30%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.73
+0.36(+4.30%)
Currency In USD
| Previous Close | 8.37 |
| Open | 8.32 |
| Day High | 8.81 |
| Day Low | 8.31 |
| 52-Week High | 12.54 |
| 52-Week Low | 2.03 |
| Volume | 823,379 |
| Average Volume | 1.89M |
| Market Cap | 1.17B |
| PE | 291 |
| EPS | 0.03 |
| Moving Average 50 Days | 9.89 |
| Moving Average 200 Days | 7.11 |
| Change | 0.36 |
Thiogenesis Receives Final Acceptance from TSXV for Its Over-Subscribed Non-Brokered Private Placement of Common Shares
Newsfile
Aug 14, 2025 12:00 PM GMT
San Diego, California--(Newsfile Corp. - August 14, 2025) - Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company") is pleased to announce that, further to its news release of August 1, 2025, it has received final acceptance from
Thiogenesis Raises over C$4.14 Million in Non-Brokered Private Placement of Common Shares
Newsfile
Aug 01, 2025 12:00 PM GMT
San Diego, California--(Newsfile Corp. - August 1, 2025) - Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company") is pleased to announce that, further to its news releases of July 17 and July 29, 2025, it has closed a heavily ove
Thiogenesis Upsizes Fully Subscribed Non-Brokered Private Placement of Common Shares
Newsfile
Jul 29, 2025 12:00 PM GMT
San Diego, California--(Newsfile Corp. - July 29, 2025) - Further to its news release of July 17, 2025, Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company") is very pleased to announce that, due to overwhelming investor demand,